Total semaglutide used per 4-week maintenance cycle: 9.6 mg At this dose, a single 10mg vial lasts approximately 4 weeks
This dual-action mechanism not only aids in weight management but also represents a significant advancement in the treatment of obesity-related health issues, making it a valuable option for patients who have struggled with traditional weight loss methods
Semaglutide works by mimicking a natural hormone called GLP-1 (glucagon-like peptide-1), which helps regulate both digestion and metabolic processes, contributing to improved blood sugar within a healthy range, appetite control, and a balanced digestive process
Smriti Choudhary, MD , this once-weekly injection works to reduce hunger, increase satiety, and support fat loss, helping you achieve your weight loss goals more effectively
Tirzepatide for Type 2 Diabetes (Mounjaro) Initiated at 2.5 mg weekly (to build tolerance) Bumped to 5 mg after 4 weeks, then titrated by 2.5 mg every 4 weeks as needed Dose adjustment guided by glycemic control (HbA1c targets) and side effect tolerability Typically used alongside diet and exercise and can be combined with other diabetes medications excluding type 1 diabetes Tirzepatide for Obesity (Zepbound) Initiated similarly at 2.5 mg weekly Increased to 5 mg after 4 weeks, with potential further titrations every 4 weeks in 2.5 mg steps Recommended maintenance doses for weight loss are 5 mg, 10 mg, or 15 mg weekly Also indicated for moderate to severe obstructive sleep apnea (OSA) related to obesity, often with doses of 10 mg or 15 mg Prescribed alongside a reduced-calorie diet and increased physical activity Why Gradual Dose Increases Matter Gastrointestinal side effects (nausea, diarrhea, vomiting) are common during initiation and can be dose-limiting Slow titration allows for better medication tolerance and improved adherence Adjustments are based on individual response and tolerance, highlighting the importance of medically supervised care Special Considerations: Who Needs Careful Monitoring
